| [The time course of changes in cell immunological parameters during administration of live dry plague vaccine] [English Abstract, Journal Article]
Klin Lab Diagn 2009 Aug; (8):24-7.
Abstract | Full Citation |
| Putre L
Hospital staff goes into overdrive during anthrax scare. [News]
Hosp Health Netw 2009 Sep; 83(9):18.
Full Citation | Find Related Articles |
| Nguyen ML, Terzyan S, Ballard JD, et al.
The Major Neutralizing Antibody Responses to Recombinant Anthrax Lethal Factor and Edema Factors Are Directed to Non-Cross-Reactive Epitopes. [JOURNAL ARTICLE]
Infect Immun 2009 Aug 31.
Abstract | Full Citation |
| Kelly-Cirino CD, Mantis NJ
NEUTRALIZING MONOCLONAL ANTIBODIES DIRECTED AGAINST DEFINED LINEAR EPITOPES ON DOMAIN 4 OF ANTHRAX PROTECTIVE ANTIGEN. [JOURNAL ARTICLE]
Infect Immun 2009 Aug 24.
Abstract | Full Citation | Find Related Articles |
| Cao S, Guo A, Liu Z, et al.
Investigation of New Dominant Negative Inhibitors of Anthrax Protective Antigen Mutants for use in Therapy and Vaccination. [JOURNAL ARTICLE]
Infect Immun 2009 Jul 20.
Abstract | Full Citation |
| Margolis AR, Grabenstein JD
Immunizations against bioterrorism: smallpox and anthrax. [Journal Article]
J Am Pharm Assoc (2003) 2009 Jul-Aug; 49(4):566-8.
Full Citation |
| Parreiras PM, Sirota LA, Wagner LD, et al.
Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines. [JOURNAL ARTICLE]
Vaccine 2009 Jun 3.
Abstract | Full Citation |
| Leckenby MW, Spear AM, Neeson BN, et al.
Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration. [Journal Article]
Microb Pathog 2009 Apr; 46(4):201-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Oscherwitz J, Yu F, Jacobs JL, et al.
A synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen. [JOURNAL ARTICLE]
Infect Immun 2009 Jun 1.
Abstract | Full Citation | Find Related Articles |
| McGowen AL, Hale LP, Shelburne CP, et al.
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. [JOURNAL ARTICLE]
Vaccine 2009 Jun 2; 27(27):3544-3552.
Abstract | Full Citation | Find Related Articles |
  |
